Steven M. Kwasny

890 citations

17 papers · 685 indexed · h-index 10

Co-authors: Timothy J. Opperman Terry L. Bowlin Son T. Nguyen Hong‐Suk Kim Hiroshi Nikaido Norton P. Peet Xiaoyuan Ding John D. Williams
Topics: Antibiotic Resistance in Bacteria (4 papers)Antimicrobial Peptides and Activities (4 papers)Biochemical and Structural Characterization (3 papers)
Cited by: Molecular Medicine Microbiology Endocrinology
Journals: Proceedings of the National Academy of Sciences Nature Communications PLoS ONE
Partner nations: United States Switzerland Italy

In The Last Decade

Steven M. Kwasny

16 papers receiving 659 citations

Peers

Countries citing papers authored by Steven M. Kwasny

Since Specialization

Citations

This map shows the geographic impact of Steven M. Kwasny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Kwasny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Kwasny more than expected).

Fields of papers citing papers by Steven M. Kwasny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Kwasny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Kwasny. The network helps show where Steven M. Kwasny may publish in the future.

Co-authorship network of co-authors of Steven M. Kwasny

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Kwasny. A scholar is included among the top collaborators of Steven M. Kwasny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Kwasny. Steven M. Kwasny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus 2022 ·Antiviral Research ·(unknown),(unknown),Thomas J. Gardner,(unknown),(unknown),Steven M. Kwasny,Steven C. Cardinale,(unknown),Mark N. Prichard,Scott H. James,(unknown),(unknown),Terry L. Bowlin,Timothy J. Opperman,Domenico Tortorella	3
2	Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial Leads 2022 ·Molecular Pharmacology ·Michelle M. Butler,Samanthi L. Waidyarachchi,(unknown),Son T. Nguyen,Xiaoyuan Ding,Steven C. Cardinale,(unknown),Steven M. Kwasny,Mai Ito,(unknown),(unknown),Íñigo Angulo‐Barturen,Robert T. Jacobs,Jeremy N. Burrows,Zachary D. Aron,Terry L. Bowlin,Sanjay A. Desai	5
3	trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo 2021 ·Nature Communications ·Zachary D. Aron,(unknown),Eric D. Hoffer,Kristie L. Connolly,Pooja Srinivas,(unknown),John N. Alumasa,Mynthia Cabrera,(unknown),(unknown),Steven C. Cardinale,Steven M. Kwasny,(unknown),Michelle M. Butler,Timothy J. Opperman,Terry L. Bowlin,Ann E. Jerse,Scott M. Stagg,C.M. Dunham,Kenneth C. Keiler	29
4	Optimization of a small-molecule Lipid II binder 2019 ·Bioorganic & Medicinal Chemistry Letters ·Jay Chauhan,Steven M. Kwasny,Steven Fletcher,(unknown),(unknown)	0
5	Pleiotropic Anti-Infective Effects of Defensin-Derived Antimicrobial Compounds 2018 ·Avian Diseases ·(unknown),Sung Hyen Lee,Woo Hyun Kim,Steven M. Kwasny,(unknown),Hyun S. Lillehoj	2
6	Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics 2016 ·PLoS ONE ·(unknown),Steven C. Cardinale,Lei Fang,Jing Huang,Steven M. Kwasny,M. Ross Pennington,(unknown),(unknown),Benedict R. Capacio,Alexander D. MacKerell,(unknown),Steven Fletcher,(unknown)	6
7	Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives 2016 ·Proceedings of the National Academy of Sciences ·Hanno Sjuts,Attilio V. Vargiu,Steven M. Kwasny,Son T. Nguyen,Hong‐Suk Kim,Xiaoyuan Ding,(unknown),Paolo Ruggerone,Terry L. Bowlin,Hiroshi Nikaido,Klaas M. Pos,Timothy J. Opperman	161
8	DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics 2016 ·Antimicrobial Agents and Chemotherapy ·Timothy J. Opperman,Steven M. Kwasny,(unknown),Mark A. Lewis,Daniel Andrew Aiello,John D. Williams,Norton P. Peet,Donald T. Moir,Terry L. Bowlin,Eric C. Long	21
9	Structure–activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·Son T. Nguyen,Steven M. Kwasny,Xiaoyuan Ding,Steven C. Cardinale,(unknown),Hong‐Suk Kim,Hiroshi Nikaido,Norton P. Peet,John D. Williams,Terry L. Bowlin,Timothy J. Opperman	65
10	Structure–activity exploration of a small-molecule Lipid II inhibitor 2015 ·Drug Design Development and Therapy ·Erik de Leeuw,Steven Fletcher,Wenbo Yu,Jing Huang,Steven M. Kwasny,Jay Chauhan,(unknown),(unknown)	9
11	Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds 2015 ·Bioorganic & Medicinal Chemistry ·Son T. Nguyen,Steven M. Kwasny,Xiaoyuan Ding,John D. Williams,Norton P. Peet,Terry L. Bowlin,(unknown)	22
12	Discovery of Bacterial Fatty Acid Synthase Type II Inhibitors Using a Novel Cellular Bioluminescent Reporter Assay 2015 ·Antimicrobial Agents and Chemotherapy ·Joselynn Wallace,(unknown),Debra M. Mills,Panatda Saenkham,Steven M. Kwasny,Timothy J. Opperman,John D. Williams,Charles O. Rock,Terry L. Bowlin,Donald T. Moir	14
13	Detour of prenostodione synthesis towards pyrazolones for antibacterial activity 2013 ·Bioorganic & Medicinal Chemistry Letters ·Sivappa Rasapalli,(unknown),(unknown),Christiaan A. Rees,(unknown),James A. Golen,Jerry P. Jasinski,Arnold L. Rheingold,Steven M. Kwasny,(unknown)	17
14	Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli 2013 ·Antimicrobial Agents and Chemotherapy ·Timothy J. Opperman,Steven M. Kwasny,Hong‐Suk Kim,Son T. Nguyen,(unknown),Sanjay D’Souza,Graham C. Walker,Norton P. Peet,Hiroshi Nikaido,Terry L. Bowlin	154
15	Design, synthesis and activities of 4/5-acyl-2-aminoimidazolyl analogues of oroidin for biofilm inhibition 2013 ·MedChemComm ·Sivappa Rasapalli,(unknown),Christiaan A. Rees,James A. Golen,Bal Ram Singh,Shuowei Cai,Jerry P. Jasinski,Steven M. Kwasny,Donald T. Moir,(unknown),Terry L. Bowlin	4
16	Static Biofilm Cultures of Gram‐Positive Pathogens Grown in a Microtiter Format Used for Anti‐Biofilm Drug Discovery 2010 ·Current Protocols in Pharmacology ·Steven M. Kwasny,Timothy J. Opperman	127
17	Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm Formation 2009 ·Antimicrobial Agents and Chemotherapy ·(unknown),Steven M. Kwasny,John D. Williams,Atiyya R. Khan,Norton P. Peet,Donald T. Moir,Terry L. Bowlin	46

About Steven M. Kwasny

Steven M. Kwasny is a scholar working on Molecular Medicine, Microbiology and Toxicology, having authored 17 papers that have together received 685 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Peptides and Activities (4 papers) and Biochemical and Structural Characterization (3 papers). The work is most often cited by research in Molecular Medicine (312 citations), Microbiology (76 citations) and Endocrinology (39 citations). Steven M. Kwasny has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Timothy J. Opperman, Terry L. Bowlin, Son T. Nguyen, Hong‐Suk Kim, Hiroshi Nikaido, Norton P. Peet, Xiaoyuan Ding, John D. Williams, Graham C. Walker and Sanjay D’Souza. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact